tiprankstipranks
Serina Therapeutics (SER)
:SER
US Market
SER
Serina Therapeutics
RESEARCH TOOLSreports

Serina Therapeutics (SER) Income Statement

258 Followers

Serina Therapeutics Income Statement

Last quarter (Q4 2025), Serina Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Serina Therapeutics's net income was $-3.34M. See Serina Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Mar 23Dec 21
Total Revenue
$ 130.00K$ 56.00K$ 3.15M$ 500.00K$ 3.46M
Gross Profit
$ 45.00K$ -138.00K$ 3.06M$ 500.00K$ -333.84K
Operating Expenses
$ 24.02M$ 16.91M$ 6.19M$ 2.77M$ 1.30M
Depreciation and Amortization
$ 85.00K$ 194.00K$ 90.00K$ 61.27K$ 33.37K
EBITDA
$ -24.02M$ -10.49M$ 5.92M$ -2.60M$ -1.23M
Operating Income
$ -24.02M$ -17.05M$ -3.13M$ -2.27M$ -1.63M
Other Income/Expenses
$ 4.83M$ 5.84M$ 8.40M$ -411.74K$ 366.81K
Pretax Income
$ -19.20M$ -11.21M$ 5.27M$ -2.68M$ -1.26M
Net Income
$ -19.18M$ -11.14M$ 5.27M$ -2.68M$ -1.26M
Per Share Metrics
Basic EPS
$ -1.91$ -1.51$ 0.63$ -2.49$ -0.59
Diluted EPS
$ -1.91$ -1.51$ 0.63$ -2.49$ -0.59
Weighted Average Shares Outstanding
 10.19M 7.36M 8.41M 1.08M 1.08M
Weighted Average Shares Outstanding (Diluted)
 10.19M 7.36M 8.41M 1.08M 1.08M
Currency in USD

Serina Therapeutics Earnings and Revenue History